12,372 trials
Rheumatoid Arthritis
Primary: Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 12 — 35.7; 63.8; 66.2 percentage of participants — p=<0.001
Keratitis · Corneal Ulcer
Primary: Number of Participants With a Reduction in Neurotrophic the Keratitis/Ulcer Area on Day28 — 37; 44 Participants
Rheumatoid Arthritis
Primary: Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 12 — 28.4; 64.6; 56.4 percentage of participants — p=<0.001
Non-melanoma Skin Cancer
Primary: Maximum Pain Score — 2.8; 1.2 units on a pain scale
Asthma
Primary: Change From Baseline (Visit 4) to Day 28 (Visit 8), Day 56 (Visit 9), and Day 84 (Visit 10) in Pre-BD FEV1 — 0.21; 0.132; 0.22; 0.203 Liter — p=0.0707
Rheumatoid Arthritis
Primary: Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 14 — 41.2; 67.7; 71.2 percentage of participants — p=<0.001
Primary Immunodeficiency
Primary: AUC in the IV Phase and SC Phases: Steady-state AUC of Total IgG Over a Regular Dosing Interval — 207921.5; 213141.4 h*mg/dL
Contraception
Primary: The Number of On-treatment Pregnancies (With + 2-day Window) Per 100 Woman-years of Exposure (Pearl Index) in Subjects Aged 18 to 35 Years, Inclusive, at the Time of…
Rheumatoid Arthritis
Primary: Percentage of Participants With an American College of Rheumatology 50% (ACR50) Response at Week 12 - Global Analysis — 28.3; 52.1; 56.4 percentage of participants…
Schizophrenia
Primary: Mean Change From Baseline to Week 6 in Positive and Negative Syndrome Scale (PANSS) Total Score — -2.68; -4.59; -3.42; -3.09 units on a scale
Invasive Breast Cancer
Primary: Percentage of Participants With Moist Desquamation — 66.7; 43.8 % of participants w/moist desquamation
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
Primary: Overall Survival (OS) — 6.5; 7.6; 8.3 Months — p=0.7624
Precapillary Pulmonary Hypertension
Primary: Changes in Right Ventricular Ejection Fraction (RVEF %) After 3 Months Intervention — -2.8; 3.9 percentage of ejected blood — p=0.008
Breast Cancer
Primary: Disease-free Survival After Prolonged Endocrine Treatment — NA; NA Years — p=0.425
Complicated Urinary Tract Infections
Primary: Proportion of Participants in the Micro-ITT Population Demonstrating Clinical Cure and Microbiologic Success at the EOI Visit — 363; 382; 51; 7 Participants